CPC A61K 31/65 (2013.01) [A61K 31/663 (2013.01); A61P 25/28 (2018.01)] | 12 Claims |
1. A method of treating cytomegalovirus (CMV) related diseases in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound that modifies microglia,
wherein the compound is clodronate or a tetracycline family compound, and
wherein the CMV related disease is a disorder associated with perinatal or congenital CMV infection selected from the group consisting of microcephaly, polymicrogyria, hearing loss, cerebral palsy, epileptic seizures and intellectual disability.
|